Thermo Fisher: Life Science Juggernaut On The Path To $1 Trillion In Market Cap


  • Thermo Fisher Scientific is an under-the-radar healthcare company that prints money.
  • What does Thermo Fisher do? Science! Some examples – manufacturing of lab equipment, diagnostic tests, and vaccines. They have a fast-growing clinical research business as well.
  • Thermo Fisher supports the global healthcare and life sciences industries and earns roughly half of its revenue outside of the United States.
  • The stock has been a juggernaut, and importantly, its success in recent years has been driven almost entirely by the business and not by investor speculation.
  • Analysts underestimate Thermo Fisher, but it keeps on growing.
Thermo Fisher Scientific facilities in Silicon Valley

Sundry Photography

Thermo Fisher Scientific Inc. (NYSE:TMO) made roughly $7.7 billion in net income last year. Ever heard of them? Most people haven’t, but the Massachusetts-based company is among the largest suppliers to the global healthcare industry. Along with its competitor Danaher (

Disclosure: I/we have a beneficial long position in the shares of TMO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Leave a Reply

Your email address will not be published. Required fields are marked *